Mots-C
Mitochondrial open reading frame of the 12S rRNA-c, MT-RNR1, Mitochondrial-derived peptide MOTS-c
MOTS-c and aerobic exercise induce cardiac physiological adaptation via NRG1/ErbB4/CEBPβ modification in rats.
Yuan. Jinghan J; Xu. Bowen B; Ma. Jiacheng J; Pang. Xiaoli X; Fu. Yu Y; Liang. Min M; Wang. Manda M; Pan. Yanrong Y; Duan. Yimei Y; Tang. Mi M; Zhu. Bingmei B; Laher. Ismail I; Li. Shunchang S
Key Findings
- MOTS‑c treatment increased heart weight and muscle fiber thickness, mirroring the effects of aerobic training.
- Both MOTS‑c and exercise improved cardiac performance metrics (lower heart rate, higher dP/dt max/min) without raising end‑diastolic pressure.
- The benefits were associated with up‑regulation of NRG1, ErbB4, and Gata4 and down‑regulation of C/EBPβ, indicating a shared molecular pathway.
Practical Outcomes
- For biohackers, MOTS‑c shows promise as a supplement that could support heart health in a way similar to aerobic exercise, but the evidence is limited to animal studies. Until human trials confirm safety, effective dosing, and real‑world benefits, it should not replace regular exercise. Consider it an experimental adjunct, not a primary strategy for cardiac conditioning.
Summary
In rats, giving the mitochondrial peptide MOTS‑c or doing regular aerobic exercise both made the heart bigger, the muscle fibers thicker, and improved how well the heart pumped, without raising harmful pressure. These benefits were linked to activation of a specific signaling pathway (NRG1‑ErbB4‑C/EBPβ). The peptide acted in a very similar way to exercise.
Abstract
To determine the effects of the mitochondrial open reading frame of the 12S ribosomal RNA type-c (MOTS-c) and aerobic exercise on cardiac structure and function and explore the role of neuregulin-1 (NRG1)- ErbB2 receptor tyrosine kinase 4(ErbB4)- CCAAT-enhancer binding protein β (C/EBPβ) in cardiac physiological adaptation induced by MOTS-c and aerobic training. We used Hematoxylin-Eosin staining(HE)and Transmission Electron Microscope (TEM) to observe the cardiac myocardial structure, carotid artery catheterization to test cardiac function, and real-time quantitative polymerase chain reaction (qRT-PCR) and Western blotting to describe the changes of NRG1, ErbB4, C/EBPβ, and Gata in cardiac physiological adaptation. MOTS-c and aerobic training significantly increased heart weight and heart weight index (HWI) (all p < 0.05). Aerobic exercise and MOTS-c treatment thickened myocardial fibers, with a tendency of hypertrophy. Heart rate (HR) (p < 0.001, p = 0.010, p = 0.011), the isovolumic diastolic time constant (Tau) (p < 0.001, p < 0.001, p < 0.001) in exercised (E), MOST-c treated (M) and their combination (ME) decreased significantly, while the dP/dt<sub>max</sub> (p < 0.001, p < 0.001, p = 0.039) and dP/dt<sub>min</sub> (p < 0.001, p < 0.001, p = 0.001) in groups E, M and ME were significantly higher than those in group C, but EDP (p = 0.903, p = 0.708, p = 0.744) remained unchanged. Moreover, C/EBPβ gene levels were significantly decreased in the differential gene expression between groups C and M transcriptomics sequencing. The levels of ErbB4 mRNA (p < 0.001, p < 0.001, p < 0.001) and Gata4 mRNA (p < 0.001, p < 0.001, p = 0.001) in groups E, M and ME increased significantly, while C/EBPβ mRNA expression decreased significantly (p < 0.001, p = 0.002, p = 0.001), which was consistent with the results of transcriptome sequencing. NRG1 mRNA in group E was significantly higher than that in group C (p = 0.003), but there was no significant difference between groups M and ME (p = 0.804, p = 0.320). The protein expression of NRG1 (p = 0.026, p < 0.001, p < 0.001), ErbB4 (p < 0.001, p < 0.001, p < 0.001) and Gata4 (p = 0.014, p < 0.001, p = 0.006) in groups E, M and ME increased significantly, while C/EBPβ decreased significantly (p < 0.001, p = 0.001, p = 0.002). Our findings suggest that MOTS-c and aerobic exercise had similar effects, improving myocardial morphology and structure and enhancing cardiac function through activation of the NRG1-ErbB4-C/EBPβ pathway.
Study Information
pubmed
2022
2022-12-28T00:00:00.000Z
10.1016/j.lfs.2022.121330
6
46